Abstract
In the present article, structural, neurochemical and functional neuroimaging investigations performed on patients with social anxiety disorder were reviewed. A PubMed search was performed to identify all structural and functional neuroimaging studies published between 1980 and February 2013. The studies and case reports on neuroimaging in social anxiety disorder were grouped under the subheadings of structural, functional and magnetic resonance spectroscopic imaging. It seems that structural studies involve examination of abnormalities in the basal ganglia structures like caudate nucleus, thalamus, and putamen, hippocampus and amygdala abnormalities in summary. Neurochemical investigations reveal the deficiencies in the GABAergic system and over-activation in the glutamatergic system in social anxiety disorder. Functional neuroimaging investigations implicate the role of limbic-medial prefrontal circuit.
Keywords: Social anxiety disorder, neuroimaging, structural, functional, MRI.
Reviews on Recent Clinical Trials
Title:What About the Neuroimaging Findings in Social Anxiety Disorder?
Volume: 8 Issue: 2
Author(s): Murad Atmaca
Affiliation:
Keywords: Social anxiety disorder, neuroimaging, structural, functional, MRI.
Abstract: In the present article, structural, neurochemical and functional neuroimaging investigations performed on patients with social anxiety disorder were reviewed. A PubMed search was performed to identify all structural and functional neuroimaging studies published between 1980 and February 2013. The studies and case reports on neuroimaging in social anxiety disorder were grouped under the subheadings of structural, functional and magnetic resonance spectroscopic imaging. It seems that structural studies involve examination of abnormalities in the basal ganglia structures like caudate nucleus, thalamus, and putamen, hippocampus and amygdala abnormalities in summary. Neurochemical investigations reveal the deficiencies in the GABAergic system and over-activation in the glutamatergic system in social anxiety disorder. Functional neuroimaging investigations implicate the role of limbic-medial prefrontal circuit.
Export Options
About this article
Cite this article as:
Atmaca Murad, What About the Neuroimaging Findings in Social Anxiety Disorder?, Reviews on Recent Clinical Trials 2013; 8 (2) . https://dx.doi.org/10.2174/15748871113086660050
DOI https://dx.doi.org/10.2174/15748871113086660050 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Combination Treatment in Alzheimers Disease: Results of a Randomized, Controlled Trial with Cerebrolysin and Donepezil
Current Alzheimer Research Gene Transfer to the Central Nervous System: Current State of the Art of the Viral Vectors
Current Genomics HIV-1-Associated Dementia During HAART Therapy
Recent Patents on CNS Drug Discovery (Discontinued) The Role of N-Methyl-D-Aspartate Receptor - Mediated Neurotransmission in Attention Deficit (Hyperactivity) Disorder (ADHD/ADD)
Current Psychopharmacology Protein Kinases and their Modulation in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents Neuroprotection Abilities of Cytosolic Phospholipase A2 Inhibitors in Kainic acid-induced Neurodegeneration
Current Drug Targets - Cardiovascular & Hematological Disorders Involvement of Uridine-Nucleotide-Stimulated P2Y Receptors in Neuronal Growth and Function
Central Nervous System Agents in Medicinal Chemistry The Critical Role of Insulin-Like Growth Factor-1 Isoforms in the Physiopathology of Skeletal Muscle
Current Genomics Is rTMS an Effective Therapeutic Strategy that Can Be Used to Treat Parkinson's Disease?
CNS & Neurological Disorders - Drug Targets Neuritin, A Neurotrophic Factor in Nervous System Physiology
Current Medicinal Chemistry Allosteric Modulation of Muscarinic Acetylcholine Receptors
Current Neuropharmacology Drug Abuse, Brain Calcification and Glutamate-Induced Neurodegeneration
Current Drug Abuse Reviews Green Tea, A Medicinal Food with Promising Neurological Benefits
Current Neuropharmacology Oxidative Stress, Antioxidants and Neurodegenerative Diseases
Current Pharmaceutical Design Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis
Current Neuropharmacology Functional Connectivity in a Rat Model of Alzheimer's Disease During a Working Memory Task
Current Alzheimer Research Melatonin Synthetic Analogs as Nitric Oxide Synthase Inhibitors
Mini-Reviews in Medicinal Chemistry Mesenchymal Stem Cells Neuronal Differentiation Ability: A Real Perspective for Nervous System Repair?
Current Stem Cell Research & Therapy The Pro-Apoptotic Substance Thapsigargin Selectively Stimulates Re-Growth of Brain Capillaries
Current Neurovascular Research Neurovascular Changes in Acute, sub-Acute and Chronic Mouse Models of Parkinson’s Disease
Current Neurovascular Research